Showing results (61-70 of 418) with videos related to
Sort By:
Pageof 42
BMJ Case Reports|November 20, 2015
Radium-223 dichloride therapy in breast cancer with osseous metastasesAmol Takalkar, Bhavna Paryani, Scott Adams, et al.The Oncologist|July 25, 2019
Artificial Intelligence Systems Assisting Oncologists? Resist and Desist or Enlist and CoexistJacob J Adashek, Ishwaria M Subbiah, Vivek SubbiahJournal of Breast Cancer|October 17, 2014
Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA MutationRishi Agarwal, Kimberly Koenig, Eric Rohren, et al.Frontiers in Medicine|December 2, 2022
Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227Peter M Anderson, Vivek Subbiah, Matteo M TruccoBioorganic & Medicinal Chemistry|November 26, 2009
The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derruboneJared R Mays, Stephanie A Hill, Justin T Moyers, et al.JCO Precision Oncology|September 11, 2020
Precision Oncology in Sarcomas: Divide and ConquerRoberto Carmagnani Pestana, Roman Groisberg, Jason Roszik, et al.Diagnostics (Basel, Switzerland)|February 18, 2017
Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future PerspectivesVivek Subbiah, Hubert H Chuang, Dhiraj Gambhire, et al.Journal of Medical Case Reports|November 27, 2007
Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case reportVivek Subbiah, Uyen K Ly, Amer Khiyami, et al.JCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.Diagnostics (Basel, Switzerland)|September 14, 2024
Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake AnalysisKalevi Kairemo, Homer A Macapinlac, Mohammed Gouda, et al.Pageof 42